Clinical Trial Update: Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

A phase 2 trial evaluated the combination of epirubicin and vinorelbine for stage II-IV breast cancer. The study was terminated, and results were posted in 2013…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Epirubicin (epirubicin)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-11-25